Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B

Transplant Infectious Disease

Volumn 14, Issue 2, 2012, Pages 184-187

  Hosokawa, K ^a   Yamazaki, H ^a   Mochizuki, K ^a   Ohata, K ^a   Ishiyama, K ^b   Hayashi, T ^a   Kondo, Y ^a   Sugimori, N ^a   Okumura, H ^a   Takami, A ^a   Nakao, S ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b Tokyo Metropolitan Ohtsuka Hospital   (Japan)

Author keywords

Acute myeloid leukemia; Combination therapy; L AmB; M CSF; Trichosporon fungemia; Voriconazole

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CD33 ANTIGEN; CD7 ANTIGEN; CEFEPIME; CIPROFLOXACIN; COLONY STIMULATING FACTOR; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; FLUCONAZOLE; FLUCYTOSINE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; MELPHALAN; MEROPENEM; METHOTREXATE; MICAFUNGIN; MIRIMOSTIM; MONOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VANCOMYCIN; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPIDIDYMITIS; FEBRILE NEUTROPENIA; GINGIVA DISEASE; GRAFT VERSUS HOST REACTION; HUMAN; INFECTION; INFECTION PREVENTION; LEUKEMIA RELAPSE; LEUKOCYTE COUNT; MALE; MYCOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; TRICHOSPORON; TRICHOSPORON ASAHII; TRICHOSPORON FUNGEMIA; WHOLE BODY RADIATION;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BONE MARROW TRANSPLANTATION; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FUNGEMIA; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; PYRIMIDINES; TRIAZOLES; TRICHOSPORON; TRICHOSPORONOSIS; YOUNG ADULT;

EID: 84859849600     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00670.x     Document Type: Article

References (13)

1. Krcmery V Jr, Mateicka F, Kunova A, et al. Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazole. Support Care Cancer 1999; 7 (1): 39-43.
2. Thibeault R, Champagne M, de Repentigny L, et al. Fatal disseminated Trichosporon asahii infection in a child with acute lymphoblastic leukemia. Can J Infect Dis Med Microbiol 2008; 19 (2): 203-205.
3. Antachopoulos C, Papakonstantinou E, Dotis J, et al. Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole. J Pediatr Hematol Oncol 2005; 27 (5): 283-285.
4. Matsue K, Uryu H, Koseki M, Asada N, Takeuchi M. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Clin Infect Dis 2006; 42 (6): 753-757.
5. Girmenia C, Pagano L, Martino B, et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 2005; 43 (4): 1818-1828.
6. Erer B, Galimberti M, Lucarelli G, et al. Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts. Bone Marrow Transplant 2000; 25 (7): 745-749.
7. Kontoyiannis DP, Torres HA, Chagua M, et al. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis 2004; 36 (8): 564-569.
8. Anaissie E, Gokaslan A, Hachem R, et al. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin Infect Dis 1992; 15 (5): 781-787.
9. Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004; 42 (10): 4419-4431.
10. Tawara S, Ikeda F, Maki K, et al. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi. Antimicrob Agents Chemother 2000; 44 (1): 57-62.
11. Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH. In vitro antifungal susceptibilities of Trichosporon species. Antimicrob Agents Chemother 2002; 46 (4): 1144-1146.
12. Fournier S, Pavageau W, Feuillhade M, et al. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia. Eur J Clin Microbiol Infect Dis 2002; 21 (12): 892-896.
13. Nemunaitis J, Shannon-Dorcy K, Appelbaum FR, et al. Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood 1993; 82 (5): 1422-1427.